News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
US Drug Pricing and Reimbursement: Players, Payers, PBMs, and Prospects A Conversation with Two Experts
In late 2023, The Wall Street Journal published an article which examined interactions between patient health insurance prescription benefits, pharmacies, and pharmacy benefit managers (PBMs), and their collective impact on the prices that patients pay for their prescription drugs in the US. Former DIA Global Head of Science and Scientific Strategy Courtney Granville discussed this article and the topics it raises with Parexel market access experts Brian Duda and Wyatt Gotbetter.